eMedicine Specialties > Cardiology > Arrhythmias

Lown-Ganong-Levine Syndrome: Follow-up

Author: Daniel M Beyerbach, MD, PhD,, Consulting Staff, Florida Electrophysiology Associates; Affiliate Clinical Assistant Professor of Biomedical Science, Florida Atlantic University, Regional Campus of University of Miami Miller School of Medicine
Coauthor(s): Christopher Cadman, MD, Director of Arrhythmia Service, Assistant Professor, Department of Internal Medicine, Division of Cardiology, University of New Mexico
Contributor Information and Disclosures

Updated: Sep 4, 2009

Follow-up

Further Inpatient Care

  • Admit patients in unstable condition to telemetry.
  • Institute pharmacologic therapy as dictated by symptoms and documented tachycardia.
  • Order consultations as discussed in Treatment.
  • Consider exercise treadmill testing if tachycardia is induced by exercise.

Further Outpatient Care

  • If no arrhythmia is documented on ECG or telemetry, and symptoms occur on a daily basis, consider Holter monitor with diary to document cardiac rhythm during symptomatic episodes.
  • If no arrhythmia is documented on ECG or telemetry, and symptoms occur less frequently than daily, consider an event recorder to document cardiac rhythm during symptomatic episodes.
  • If patient is in stable condition and does not require hospitalization, and if no tachyarrhythmia has been documented but symptoms are induced by exercise, consider outpatient exercise treadmill testing.
  • If symptoms persist, but no tachyarrhythmia can be documented by any of these methods, consider referral to an electrophysiologist for an outpatient EP study.

Inpatient & Outpatient Medications

Complications

  • Complications vary by the underlying condition.

Prognosis

  • No studies have shown an increased risk of sudden death or decreased survival for patients meeting criteria for diagnosis of LGL.

Patient Education

  • LGL is an outdated clinical diagnosis with no known unique underlying anatomic correlate. No specific risks are conferred with the diagnosis.
  • For excellent patient education resources, visit eMedicine's Heart Center. Also, see eMedicine's patient education article Supraventricular Tachycardia.

Miscellaneous

Medicolegal Pitfalls

  • Advise patients who have experienced syncope to not drive or operate vehicles of public transport for 6 months after the occurrence of the most recent episode of syncope, or until the cause of syncope has been identified and adequately treated. Within the United States, laws regarding restrictions on driving and operating vehicles of public transport after an episode of syncope vary by state.
 
Acknowledgments

Christopher Cadman, MD, contributed to the original version of this article.



More on Lown-Ganong-Levine Syndrome

Overview: Lown-Ganong-Levine Syndrome
Differential Diagnoses & Workup: Lown-Ganong-Levine Syndrome
Treatment & Medication: Lown-Ganong-Levine Syndrome
Follow-up: Lown-Ganong-Levine Syndrome
Multimedia: Lown-Ganong-Levine Syndrome
References

References

  1. Clerc A, Levy R, Critesco C. A propos du raccourcissement permanent de l'espace P-R de l'electrocardiogramme sans deformation du complex ventriculaire. Arch Mal Coeur. 1938;31:569.

  2. LOWN B, GANONG WF, LEVINE SA. The syndrome of short P-R interval, normal QRS complex and paroxysmal rapid heart action. Circulation. May 1952;5(5):693-706. [Medline].

  3. Burch GE, Kimball JL. Notes on the similarity of QRS complex configuration in Wolff-Parkinson-White syndrome. Am Heart J. 1946;32:560.

  4. James TN. Morphology of the human atrioventricular node, with remarks pertinent to its electrophysiology. Am Heart J. 1961;62:756-71.

  5. Brechenmacher C, Laham J, Iris L, et al. [Histological study of abnormal conduction pathways in the Wolff-Parkinson-White syndrome and Lown-Ganong-Levine syndrome]. Arch Mal Coeur Vaiss. May 1974;67(5):507-19. [Medline].

  6. Josephson ME, Kastor JA. Supraventricular tachycardia in Lown-Ganong-Levine syndrome: atrionodal versus intranodal reentry. Am J Cardiol. Oct 1977;40(4):521-7. [Medline].

  7. Chou TC. Wolff-Parkinson-White syndrome and its variants. In: Electrocardiography in Clinical Practice, Adult and Pediatric. 4th ed. Philadelphia:. WB Saunders Co;1996.

  8. Moller P. Letter: Criteria for the LGL syndrome. Am Heart J. Apr 1976;91(4):539-41. [Medline].

  9. Jackman WM, Prystowsky EN, Naccarelli GV, et al. Reevaluation of enhanced atrioventricular nodal conduction: evidence to suggest a continuum of normal atrioventricular nodal physiology. Circulation. Feb 1983;67(2):441-8. [Medline].

  10. Ward DE, Camm AJ, Spurrell RA. Re-entrant tachycardia using two bypass tracts and excluding AV node in short PR interval, normal QRS syndrome. Br Heart J. Oct 1978;40(10):1127-33. [Medline].

  11. Zipes DP, DeJoseph RL, Rothbaum DA. Unusual properties of accessory pathways. Circulation. Jun 1974;49(6):1200-11. [Medline].

  12. Ward DE, Camm AJ, Spurrell RAJ. Dual AH pathways in patients with and without the Lown-Ganong-Levine syndrome. Br Heart J. 1981;45:356.

  13. Benditt DG, Pritchett LC, Smith WM, et al. Characteristics of atrioventricular conduction and the spectrum of arrhythmias in lown-ganong-levine syndrome. Circulation. Mar 1978;57(3):454-65. [Medline].

  14. Denes P, Wu D, Dhingra RC, et al. Demonstration of dual A-V nodal pathways in patients with paroxysmal supraventricular tachycardia. Circulation. Sep 1973;48(3):549-55. [Medline].

  15. Mandel WJ, Danzig R, Hayakawa H. Lown-Ganong-Levine syndrome. A study using His bundle electrograms. Circulation. Oct 1971;44(4):696-708. [Medline].

  16. Douglas JE, Mandel WJ, Danzig R, Hayakawa H. Lown-Ganong-Levine syndrome. Circulation. May 1972;45(5):1143-4. [Medline].

  17. Durrer D, Schuilenburg RM, Wellens HJ. Pre-excitation revisited. Am J Cardiol. Jun 1970;25(6):690-7. [Medline].

  18. Mahaim I. Kent fibers and the A-V paraspecific conduction through the upper connections of the bundle of His-Tawara. Am Heart J. 1947;33:651.

  19. Ometto R, Thiene G, Corrado D, et al. Enhanced A-V nodal conduction (Lown-Ganong-Levine syndrome) by congenitally hypoplastic A-V node. Eur Heart J. Nov 1992;13(11):1579-84. [Medline].

  20. Caracta AR, Damato AN, Gallagher JJ, et al. Electrophysiologic studies in the syndrome of short P-R interval, normal QRS complex. Am J Cardiol. Feb 1973;31(2):245-53. [Medline].

  21. Wiener I. Syndromes of Lown-Ganong-Levine and enhanced atrioventricular nodal conduction. Am J Cardiol. Sep 1 1983;52(5):637-9. [Medline].

  22. Bauernfeind RA, Ayres BF, Wyndham CC, et al. Cycle length in atrioventricular nodal reentrant paroxysmal tachycardia with observations on the Lown-Ganong-Levine syndrome. Am J Cardiol. Jun 1980;45(6):1148-53. [Medline].

  23. Bauernfeind RA, Swiryn S, Strasberg B, et al. Analysis of anterograde and retrograde fast pathway properties in patients with dual atrioventricular nodal pathways: observations regarding the pathophysiology of the Lown-Ganong-Levine syndrome. Am J Cardiol. Feb 1 1982;49(2):283-90. [Medline].

  24. Ward DE, Camm J. Mechanisms of junctional tachycardias in the Lown-Ganong-Levine syndrome. Am Heart J. Jan 1983;105(1):169-75. [Medline].

Further Reading

Keywords

Lown-Gangong-Levine syndrome, LGL syndrome, Clerc-Levy-Critesco syndrome, enhanced atrioventricular nodal conduction, accelerated atrioventricular nodal conduction, short PR/normal QRS syndrome, short PR/narrow QRS syndrome, accessory pathway, WPW syndrome, Wolff-Parkinson-White syndrome

Contributor Information and Disclosures

Author

Daniel M Beyerbach, MD, PhD,, Consulting Staff, Florida Electrophysiology Associates; Affiliate Clinical Assistant Professor of Biomedical Science, Florida Atlantic University, Regional Campus of University of Miami Miller School of Medicine
Daniel M Beyerbach, MD, PhD, is a member of the following medical societies: American College of Cardiology
Disclosure: Nothing to disclose.

Coauthor(s)

Christopher Cadman, MD, Director of Arrhythmia Service, Assistant Professor, Department of Internal Medicine, Division of Cardiology, University of New Mexico
Christopher Cadman, MD is a member of the following medical societies: American College of Cardiology and Phi Beta Kappa
Disclosure: Nothing to disclose.

Medical Editor

Justin D Pearlman, MD, PhD, ME, MA, Director of Advanced Cardiovascular Imaging, Professor of Medicine, Professor of Radiology, Adjunct Professor, Thayer Bioengineering and Computer Science, Dartmouth-Hitchcock Medical Center
Justin D Pearlman, MD, PhD, ME, MA is a member of the following medical societies: American College of Cardiology, American College of Physicians, American Federation for Medical Research, International Society for Magnetic Resonance in Medicine, and Radiological Society of North America
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: eMedicine Salary Employment

Managing Editor

Frank M Sheridan, MD, Cardiology, Providence Everett Medical Center
Frank M Sheridan, MD is a member of the following medical societies: American College of Cardiology, American Heart Association, and Society for Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

CME Editor

Amer Suleman, MD, Consultant in Electrophysiology and Cardiovascular Medicine, Department of Internal Medicine, Division of Cardiology, Medical City Dallas Hospital
Amer Suleman, MD is a member of the following medical societies: American College of Physicians, American Heart Association, American Institute of Stress, American Society of Hypertension, Federation of American Societies for Experimental Biology, Royal Society of Medicine, and Society of Cardiac Angiography and Interventions
Disclosure: Nothing to disclose.

Chief Editor

Jeffrey N Rottman, MD, Professor of Medicine and Pharmacology, Director, Clinical Cardiac Electrophysiology Fellowship Program, Vanderbilt University School of Medicine; Chief, Department of Cardiology, Nashville Veterans Affairs Medical Center
Jeffrey N Rottman, MD is a member of the following medical societies: American Heart Association and North American Society of Pacing and Electrophysiology (NASPE)
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.